Gall Matthew 4
4 · iTeos Therapeutics, Inc. · Filed Dec 28, 2021
Insider Transaction Report
Form 4
Gall Matthew
Chief Financial Officer
Transactions
- Sale
Common Stock
2021-12-27$46.45/sh−5,000$232,250→ 14,429 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.20 to $46.77, inclusive. The reporting person undertakes to provide to iTeos Therapeutics, Inc., any security holder of iTeos Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.